Luigi Donato is an accomplished Italian researcher specializing in molecular biology and experimental medicine. With a focus on applied biology, he has made significant contributions to understanding genetic diseases such as Trimethylaminuria (TMAU) and age-related macular degeneration (AMD).
Author Metrics:
Luigi’s author metrics reflect his impact and productivity in the scientific community. With an H-Index of 24 and over 950 citations, he has demonstrated the significance of his research. His mean citation number and impact factors further underscore the quality and influence of his work.
ORCID Profile
Education:
Luigi holds a Ph.D. in Applied Biology and Experimental Medicine, demonstrating his advanced expertise in the field. Prior to his doctoral studies, he completed both a Laurea Magistrale and a Laurea Triennale in Biology, laying the foundation for his research career.
Research Focus:
Luigi’s research interests center around unraveling the molecular mechanisms underlying genetic diseases such as AMD and TMAU. He employs innovative approaches like cross-species RNAome analysis to identify biomarkers and therapeutic targets, contributing to advancements in personalized medicine.
Professional Journey:
Throughout his career, Luigi has held various academic and industry positions, showcasing his versatility and commitment to scientific exploration. From assistant professorships to research fellowships and startup ventures, he has continuously pursued excellence in applied biology and experimental medicine.
Honors & Awards:
Luigi’s dedication to scientific inquiry has been recognized with prestigious honors such as the Abilitazione Scientifica Nazionale and membership in the National Board of Biologists. These accolades underscore his standing as a respected authority in his field.
Publications Noted & Contributions:
With numerous peer-reviewed publications and presentations, Luigi has made significant contributions to the scientific literature. His work on AMD and TMAU has not only expanded our understanding of these diseases but has also paved the way for novel diagnostic and therapeutic strategies.
Title: Bridging Retinal and Cerebral Neurodegeneration: A Focus on Crosslinks between Alzheimer–Perusini’s Disease and Retinal Dystrophies
Journal: Biomedicines
Date: 2023-12-08
DOI: 10.3390/biomedicines11123258
Contributors: Luigi Donato; Domenico Mordà ; Concetta Scimone; Simona Alibrandi; Rosalia D’Angelo; Antonina Sidoti
Title: How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
Journal: Biomedicines
Date: 2023-07-19
DOI: 10.3390/biomedicines11072035
Contributors: Luigi Donato; Domenico Mordà ; Concetta Scimone; Simona Alibrandi; Rosalia D’Angelo; Antonina Sidoti
Title: Impaired Nuclear and Mitochondrial Cross-Talk Might Alter mtDNA Epigenetic Regulation in Maternally Inherited Diabetes- and Deafness-Affected Patients
Publication Type: Conference paper
Date: 2023-03-24
DOI: 10.3390/blsf2023021026
Contributors: Luigi Donato; Concetta Scimone; Simona Alibrandi; Maria Vadalà ; Massimo Castellucci; Domenico Mordà ; Carmela Rinaldi; Rosalia D’Angelo; Antonina Sidoti
Title: Epitranscriptome Analysis of Oxidative Stressed Retinal Epithelial Cells Depicted a Possible RNA Editing Landscape of Retinal Degeneration
Journal: Antioxidants
Date: 2022-09-30
DOI: 10.3390/antiox11101967
Contributors: Luigi Donato; Concetta Scimone; Simona Alibrandi; Sergio Zaccaria Scalinci; Carmela Rinaldi; Rosalia D’Angelo; Antonina Sidoti
Title: Supplementary Tables.zip
Publication Type: Data set
Date: 2022-08-05
DOI: 10.6084/m9.figshare.20439171
Contributors: Luigi Donato
Research Timeline:
Over the years, Luigi’s research trajectory has been marked by continuous engagement in diverse projects and collaborations. From his doctoral studies to his current endeavors, he has remained at the forefront of applied biology and experimental medicine.
Collaborations and Projects:
Luigi’s collaborative efforts span across academic and industrial settings, reflecting his interdisciplinary approach to research. His involvement in projects focusing on retinal degeneration and genetic diseases highlights his commitment to addressing complex biomedical challenges.
